COVID-19: a pandemic experience that illuminates potential reforms to health research.

Autor: Kozlowski HN; Biomedical Engineering, University of Toronto, Toronto, ON, Canada.; MD/PhD Program, Temerty Faculty of Medicine, University of Toronto, Toronto, ON, Canada., Farkouh ME; Peter Munk Cardiac Centre, Heart and Stroke Richard Lewar Centre, University of Toronto, Toronto, ON, Canada., Irwin MS; Department of Paediatrics, The Hospital for Sick Children, University of Toronto, Toronto, ON, Canada., Radvanyi LG; Ontario Institute for Cancer Research, Toronto, ON, Canada., Schimmer AD; Princess Margaret Cancer Centre, University of Toronto, Toronto, ON, Canada., Tabori U; Department of Paediatrics, The Hospital for Sick Children, University of Toronto, Toronto, ON, Canada., Rosenblum ND; Department of Paediatrics, The Hospital for Sick Children, University of Toronto, Toronto, ON, Canada.
Jazyk: angličtina
Zdroj: EMBO molecular medicine [EMBO Mol Med] 2020 Nov 06; Vol. 12 (11), pp. e13278. Date of Electronic Publication: 2020 Oct 19.
DOI: 10.15252/emmm.202013278
Abstrakt: COVID-19 has halted research around the globe and forced researchers out of their laboratories. Non-emergency medical appointments were canceled. Ongoing clinical trials were challenged to create new modes of operation while public pressure mounted to find therapeutic options against COVID-19. Yet, the inability to conduct research during COVID-19 was overcome with cooperation, resource sharing, and compassion, which provides important lessons on how to improve health related research as we enter a new normal.
(© 2020 The Authors. Published under the terms of the CC BY 4.0 license.)
Databáze: MEDLINE
Externí odkaz: